Sumitomo Pharma Co., Ltd. (4506.T)
JPY 575.0
(-0.69%)
JPY 575.0
(-0.69%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -314.96 Billion JPY | -322.71% |
| 2022 | -74.51 Billion JPY | -232.08% |
| 2021 | 56.41 Billion JPY | 0.35% |
| 2020 | 56.21 Billion JPY | 37.95% |
| 2019 | 40.75 Billion JPY | -16.19% |
| 2018 | 48.62 Billion JPY | -9.02% |
| 2017 | 53.44 Billion JPY | 84.36% |
| 2016 | 28.99 Billion JPY | 17.39% |
| 2015 | 24.69 Billion JPY | 59.88% |
| 2014 | 15.44 Billion JPY | -23.0% |
| 2013 | 20.06 Billion JPY | 99.74% |
| 2012 | 10.04 Billion JPY | 16.39% |
| 2011 | 8.62 Billion JPY | -48.62% |
| 2010 | 16.79 Billion JPY | -19.86% |
| 2009 | 20.95 Billion JPY | 4.86% |
| 2008 | 19.98 Billion JPY | -21.9% |
| 2007 | 25.59 Billion JPY | 13.21% |
| 2006 | 22.6 Billion JPY | 47.01% |
| 2005 | 15.37 Billion JPY | 122.08% |
| 2004 | 6.92 Billion JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -48.16 Billion JPY | -402.23% |
| 2024 Q1 | 15.93 Billion JPY | 108.08% |
| 2023 Q3 | -49.96 Billion JPY | -73.04% |
| 2023 Q2 | -28.87 Billion JPY | 25.69% |
| 2023 Q1 | -38.85 Billion JPY | 30.62% |
| 2023 Q4 | -197.26 Billion JPY | -294.78% |
| 2023 FY | -314.96 Billion JPY | -322.71% |
| 2022 Q2 | -38.39 Billion JPY | -223.41% |
| 2022 Q1 | 31.1 Billion JPY | 209.41% |
| 2022 Q4 | -56.01 Billion JPY | -399.24% |
| 2022 FY | -74.51 Billion JPY | -232.08% |
| 2022 Q3 | -11.21 Billion JPY | 70.78% |
| 2021 Q4 | 10.05 Billion JPY | 1.46% |
| 2021 FY | 56.41 Billion JPY | 0.35% |
| 2021 Q1 | 4.8 Billion JPY | 134.21% |
| 2021 Q2 | 31.64 Billion JPY | 559.06% |
| 2021 Q3 | 9.9 Billion JPY | -68.69% |
| 2020 FY | 56.21 Billion JPY | 37.95% |
| 2020 Q1 | 18.25 Billion JPY | 666.0% |
| 2020 Q2 | 19.03 Billion JPY | 4.27% |
| 2020 Q3 | 32.96 Billion JPY | 73.13% |
| 2020 Q4 | -14.03 Billion JPY | -142.59% |
| 2019 FY | 40.75 Billion JPY | -16.19% |
| 2019 Q1 | 6.7 Billion JPY | -22.58% |
| 2019 Q2 | 23.62 Billion JPY | 252.48% |
| 2019 Q3 | 13.64 Billion JPY | -42.23% |
| 2019 Q4 | -3.22 Billion JPY | -123.64% |
| 2018 Q1 | 15.24 Billion JPY | 433.67% |
| 2018 FY | 48.62 Billion JPY | -9.02% |
| 2018 Q2 | 12.62 Billion JPY | -17.22% |
| 2018 Q3 | 12.1 Billion JPY | -4.14% |
| 2018 Q4 | 8.65 Billion JPY | -28.45% |
| 2017 FY | 53.44 Billion JPY | 84.36% |
| 2017 Q4 | 2.85 Billion JPY | 297.99% |
| 2017 Q3 | -1.44 Billion JPY | -106.97% |
| 2017 Q2 | 20.71 Billion JPY | 43.74% |
| 2017 Q1 | 14.41 Billion JPY | 2584.48% |
| 2016 Q3 | 18.64 Billion JPY | 629.62% |
| 2016 Q1 | 8.36 Billion JPY | 518.79% |
| 2016 Q4 | -580 Million JPY | -103.11% |
| 2016 FY | 28.99 Billion JPY | 17.39% |
| 2016 Q2 | 2.55 Billion JPY | -69.45% |
| 2015 FY | 24.69 Billion JPY | 59.88% |
| 2015 Q4 | 1.35 Billion JPY | -86.65% |
| 2015 Q3 | 10.13 Billion JPY | 39.3% |
| 2015 Q2 | 7.27 Billion JPY | 22.42% |
| 2015 Q1 | 5.94 Billion JPY | 267.54% |
| 2014 Q2 | 6 Billion JPY | 4.27% |
| 2014 Q3 | 7.23 Billion JPY | 20.54% |
| 2014 Q4 | -3.54 Billion JPY | -149.01% |
| 2014 FY | 15.44 Billion JPY | -23.0% |
| 2014 Q1 | 5.75 Billion JPY | 538.14% |
| 2013 Q3 | 10.46 Billion JPY | 169.06% |
| 2013 FY | 20.06 Billion JPY | 99.74% |
| 2013 Q2 | 3.88 Billion JPY | -19.15% |
| 2013 Q1 | 4.8 Billion JPY | 170.47% |
| 2013 Q4 | 902 Million JPY | -91.38% |
| 2012 Q1 | 5.69 Billion JPY | 446.65% |
| 2012 Q2 | 5.25 Billion JPY | -7.84% |
| 2012 Q3 | 5.91 Billion JPY | 12.64% |
| 2012 Q4 | -6.82 Billion JPY | -215.35% |
| 2012 FY | 10.04 Billion JPY | 16.39% |
| 2011 Q1 | 8.08 Billion JPY | 302.69% |
| 2011 Q3 | 704 Million JPY | -52.53% |
| 2011 Q4 | -1.64 Billion JPY | -333.52% |
| 2011 FY | 8.62 Billion JPY | -48.62% |
| 2011 Q2 | 1.48 Billion JPY | -81.66% |
| 2010 Q4 | 2 Billion JPY | -67.29% |
| 2010 FY | 16.79 Billion JPY | -19.86% |
| 2010 Q2 | -626 Million JPY | -106.75% |
| 2010 Q1 | 9.27 Billion JPY | 4881.96% |
| 2010 Q3 | 6.13 Billion JPY | 1080.51% |
| 2009 FY | 20.95 Billion JPY | 4.86% |
| 2009 Q4 | -194 Million JPY | -102.28% |
| 2009 Q3 | 8.49 Billion JPY | 75.7% |
| 2009 Q2 | 4.83 Billion JPY | -38.13% |
| 2009 Q1 | 7.81 Billion JPY | 169.64% |
| 2008 Q2 | 4.42 Billion JPY | 0.0% |
| 2008 Q4 | 2.89 Billion JPY | -53.38% |
| 2008 Q3 | 6.21 Billion JPY | 40.55% |
| 2008 FY | 19.98 Billion JPY | -21.9% |
| 2007 FY | 25.59 Billion JPY | 13.21% |
| 2006 FY | 22.6 Billion JPY | 47.01% |
| 2005 FY | 15.37 Billion JPY | 122.08% |
| 2004 FY | 6.92 Billion JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 3.2 Billion JPY | 9927.426% |
| Takeda Pharmaceutical Company Limited | 144.06 Billion JPY | 318.627% |
| Shionogi & Co., Ltd. | 162.03 Billion JPY | 294.389% |
| Wakamoto Pharmaceutical Co.,Ltd. | 108.95 Million JPY | 289171.118% |
| Nippon Shinyaku Co., Ltd. | 25.85 Billion JPY | 1318.402% |
| Kaken Pharmaceutical Co., Ltd. | 8.02 Billion JPY | 4024.847% |
| Eisai Co., Ltd. | 42.4 Billion JPY | 842.729% |
| Morishita Jintan Co., Ltd. | 697 Million JPY | 45289.24% |
| Hisamitsu Pharmaceutical Co., Inc. | 13.96 Billion JPY | 2354.771% |
| Mochida Pharmaceutical Co., Ltd. | 4.54 Billion JPY | 7026.963% |
| Fuso Pharmaceutical Industries,Ltd. | 1.37 Billion JPY | 22973.566% |
| Nippon Chemiphar Co., Ltd. | -180 Million JPY | -174882.778% |
| Tsumura & Co. | 16.7 Billion JPY | 1985.252% |
| Kissei Pharmaceutical Co., Ltd. | 11.16 Billion JPY | 2922.303% |
| Torii Pharmaceutical Co., Ltd. | 4.11 Billion JPY | 7746.735% |
| Towa Pharmaceutical Co., Ltd. | 16.17 Billion JPY | 2047.499% |
| Fuji Pharma Co., Ltd. | 3.43 Billion JPY | 9269.403% |
| Zeria Pharmaceutical Co., Ltd. | 7.73 Billion JPY | 4173.966% |
| KYORIN Holdings, Inc. | 5.32 Billion JPY | 6018.245% |
| Taiko Pharmaceutical Co.,Ltd. | -4.89 Billion JPY | -6335.819% |
| Daito Pharmaceutical Co.,Ltd. | 3.29 Billion JPY | 9658.998% |
| SymBio Pharmaceuticals Limited | -1.96 Billion JPY | -15946.784% |
| MedRx Co., Ltd | -932 Million JPY | -33694.957% |
| Mizuho Medy Co.,Ltd. | 3.77 Billion JPY | 8445.232% |
| Solasia Pharma K.K. | -1.11 Billion JPY | -28224.55% |
| Modalis Therapeutics Corporation | -2.39 Billion JPY | -13068.586% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 7.54 Billion JPY | 4274.539% |
| Sawai Group Holdings Co., Ltd. | 13.69 Billion JPY | 2399.883% |
| Cyfuse Biomedical K.K. | -589.21 Million JPY | -53356.062% |
| Toho Holdings Co., Ltd. | 20.65 Billion JPY | 1624.757% |
| Koa Shoji Holdings Co.,Ltd. | 2.94 Billion JPY | 10790.189% |